Your browser doesn't support javascript.
loading
Progress in the development of small molecular inhibitors of the Bruton's tyrosine kinase (BTK) as a promising cancer therapy.
Liu, Xiu-Juan; Pang, Xiao-Jing; -Ying Yuan, Xin; Yu, Guang-Xi; Li, Yin-Ru; Guan, Yong-Feng; Zhang, Yan-Bing; Song, Jian; Zhang, Qiu-Rong; Zhang, Sai-Yang.
Afiliação
  • Liu XJ; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China.
  • Xu-Liu; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China.
  • Pang XJ; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China.
  • -Ying Yuan X; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China.
  • Yu GX; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Li YR; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Guan YF; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China.
  • Zhang YB; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China.
  • Song J; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China. Electron
  • Zhang QR; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China. Electronic address: zqr409@yeah.net.
  • Zhang SY; School of Pharmaceutical Sciences, Institute of Drug Discovery & Development, Key Laboratory of Advanced Drug Preparation Technologies (Ministry of Education), Zhengzhou University, Zhengzhou 450001, China; School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China; Henan In
Bioorg Med Chem ; 47: 116358, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34479103
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Bibliotecas de Moléculas Pequenas / Desenvolvimento de Medicamentos / Tirosina Quinase da Agamaglobulinemia / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Bibliotecas de Moléculas Pequenas / Desenvolvimento de Medicamentos / Tirosina Quinase da Agamaglobulinemia / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China